Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Nowgen
    Junior Member
    • Nov 2011
    • 4

    #1

    Reproducible workflows for NGS analysis

    Nowgen, part of the NIHR Manchester Biomedical Research Centre, a partnership between Central Manchester University Hospitals NHS Foundation Trust and The University of Manchester, is pleased to announce our forthcoming professional training course Reproducible workflows for NGS analysis. The event will be held on the 17 January 2012 at The Nowgen Centre, Manchester, UK.

    Delegates will gain practical experience in building and using workflows with the Galaxy and Taverna platforms, as well as with the myExperiment system for publishing and sharing workflows.

    For more details, a preliminary programme and course flyer please vist:

    Nowgen Training Courses
    Nowgen is a centre of excellence in public engagement, education and professional training in biomedicine.
  • Nowgen
    Junior Member
    • Nov 2011
    • 4

    #2
    Following the success of our first one-day course, Nowgen is pleased to announce that we will be running our Reproducible workflows for NGS analysis professional training course again on 11 July 2012 at the Nowgen Centre, Manchester, UK.

    Delegates will gain practical experience in building and using workflows with the Galaxy and Taverna platforms, as well as with the myExperiment system for publishing and sharing workflows.

    For more details, a preliminary programme, a course flyer and to book online please visit:

    Reproducible workflows for NGS analysis
    Nowgen is a centre of excellence in public engagement, education and professional training in biomedicine.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    11 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...